U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07155252) titled 'Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening' on Aug. 26.
Brief Summary: This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of at least one islet autoantibody) or with new onset Stage 3 T1D within 100 days from the diagnosis.
Study Start Date: Aug. 26
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes
Intervention:
DIAGNOSTIC_TE...